Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vladimir Maletic
Observed names:
Maletic, Vladimir,
V. Maletic,
Vladimir Malefic
Institutions:
University of South Carolina,
Duke University
Observed institutions:
University of South Carolina,
Duke University,
University of Toronto,
Medical College of Wisconsin,
University of California San Diego,
Stanford Medicine,
Texas Tech University Health Sciences Center,
Stanford University
show all 8
OpenAlex ID:
A5068715811
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009
·
Andrew H. Miller
, Vladimir Maletic
, et al.
·
Biological Psychiatry
·
4,289
Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis
2021
·
Felicia Ceban
, Susan Ling
, et al.
·
Brain Behavior and Immunity
·
1,809
PDF
Neurobiology of depression: an integrated view of key findings
2007
·
V. Maletic
, M. Robinson
, et al.
·
International Journal of Clinical Practice
·
468
PDF
Neurobiology of depression, fibromyalgia and neuropathic pain
2009
·
Vladimir Maletic
, Charles L Raison
·
Frontiers in bioscience
·
418
PDF
Integrated Neurobiology of Bipolar Disorder
2014
·
Vladimir Maletic
, Charles Raison
·
Frontiers in Psychiatry
·
267
PDF
The Role of Norepinephrine and Its α-Adrenergic Receptors in the Pathophysiology and Treatment of Major Depressive Disorder and Schizophrenia: A Systematic Review
2017
·
Vladimir Maletic
, Anna Eramo
, et al.
·
Frontiers in Psychiatry
·
207
PDF
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder
2023
·
Andrew J. Cutler
, Gregory W. Mattingly
, et al.
·
Translational Psychiatry
·
190
PDF
New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties
2020
·
Chungping Yu
, Jennie Garcia-Olivares
, et al.
·
Journal of Experimental Pharmacology
·
107
PDF
Painful Diabetic Neuropathy is More than Pain Alone: Examining the Role of Anxiety and Depression as Mediators and Complicators
2011
·
Rakesh Jain
, Shailesh Jain
, et al.
·
Current Diabetes Reports
·
92
Peripheral inflammatory biomarkers define biotypes of bipolar depression
2021
·
Yena Lee
, Rodrigo B. Mansur
, et al.
·
Molecular Psychiatry
·
56
Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research
2025
·
Roger S. McIntyre
, Angela T. H. Kwan
, et al.
·
American Journal of Psychiatry
·
37
Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults
2021
·
Shamia L. Faison
, Nicholas Fry
, et al.
·
Journal of Clinical Psychopharmacology
·
31
Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults
2020
·
Shamia L. Faison
, Nicholas Fry
, et al.
·
Clinical Drug Investigation
·
24
PDF
Efficacy of cariprazine in bipolar I depression across patient characteristics: a post hoc analysis of pooled randomized, placebo-controlled studies
2020
·
Mehul Patel
, Rakesh Jain
, et al.
·
International Clinical Psychopharmacology
·
23
La inflamación y sus desencantos: papel de las citocinas en la fisiopatología de la depresión mayor
2010
·
Andrew H. Miller
, Vladimir Maletic
, et al.
·
Psiquiatría Biológica
·
20
Diagnosing and Treating Patients With Mixed Features
2017
·
Rakesh Jain
, Vladimir Maletic
, et al.
·
The Journal of Clinical Psychiatry
·
19
PDF
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled Trial
2024
·
Maurizio Fava
, Stephen M. Stahl
, et al.
·
The Journal of Clinical Psychiatry
·
18
PDF
Impact of Paroxetine, a Strong CYP2D6 Inhibitor, on SPN‐812 (Viloxazine Extended‐Release) Pharmacokinetics in Healthy Adults
2021
·
Zhao Wang
, Alisa R. Kosheleff
, et al.
·
Clinical Pharmacology in Drug Development
·
17
The effect of adjunctive cariprazine on symptoms of anhedonia in patients with major depressive disorder
2025
·
Roger S. McIntyre
, Vladimir Maletic
, et al.
·
Journal of Affective Disorders
·
13
Evaluating the likelihood to be helped or harmed after treatment with viloxazine extended‐release in children and adolescents with attention‐deficit/hyperactivity disorder
2021
·
Azmi Nasser
, Alisa R. Kosheleff
, et al.
·
International Journal of Clinical Practice
·
13
Efficacy of Adjunctive Cariprazine on Anxiety Symptoms in Patients With Major Depressive Disorder: Post Hoc Analysis of a Randomized Placebo-Controlled Trial
2025
·
Maurizio Fava
, Prakash S. Masand
, et al.
·
The Journal of Clinical Psychiatry
·
12
Screening for Bipolar I Disorder and the Rapid Mood Screener: Results of a Nationwide Health Care Provider Survey
2023
·
Michael E. Thase
, Stephen M. Stahl
, et al.
·
The Primary Care Companion For CNS Disorders
·
12
PDF
Revisiting the Role of Serotonin in Attention-Deficit Hyperactivity Disorder: New Insights from Preclinical and Clinical Studies
2025
·
Matia B. Solomon
, Brittney Yegla
, et al.
·
Clinical Drug Investigation
·
11
PDF
A Review of L-Methylfolate as Adjunctive Therapy in the Treatment of Major Depressive Disorder
2023
·
Vladimir Maletic
, Richard Shelton
, et al.
·
The Primary Care Companion For CNS Disorders
·
11
Management of Painful Physical Symptoms Associated With Depression and Mood Disorders
2005
·
Thomas N. Wise
, Lesley M. Arnold
, et al.
·
CNS Spectrums
·
11
Show more works
View as search
Works count:
64
Citation count:
8,248
H-index:
17
I10-index:
26
Year
Topic
Type